Envista Holdings Corporation (NVST) Stock Analysis
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $24.96, but acceptable to hold if already in. Reason: Thin upside margin: 3.9%.
Envista Holdings is a global dental products company with $2.7B in 2025 sales through Specialty Products & Technologies (Nobel Biocare implants, Ormco orthodontics; 64% of sales) and Equipment & Consumables (DEXIS imaging, Kerr materials; 36%). Revenue comes from dentists, DSOs,... Read more
Hold if already holding. Not a fresh buy at $24.96, but acceptable to hold if already in. Reason: Thin upside margin: 3.9%. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.0/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 57d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Envista Holdings Corporation
Latest news
- NEWS Envista (NVST) Projected to Post Quarterly Earnings on Wednesday - MarketBeat — MarketBeat neutral
- NEWS NVST Stock Price Prediction 2025-2026 | Envista Holdings Corp Forecast - 24/7 Wall St. — 24/7 Wall St. positive
- NEWS NVST Stock Price Prediction 2025-2026 | Envista Holdings Corp Forecast | 24/7 Wall St. - 24/7 Wall St. — 24/7 Wall St. positive
- NEWS Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance — Yahoo Finance positive
- NEWS Earnings Flash (NVST) Envista Holdings Corporation Posts Q1 Adjusted EPS $0.36 per Share, vs. FactSet Est of $0.31 - mar — marketscreener.com positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerHenry Schein12%10-K Item 1: 'One customer, Henry Schein, Inc. ("Henry Schein"), accounted for approximately 12% of our sales for 2025 and 10% of our sales for 2024 and 2023'
- LOWGeographicChina7.0%10-K Item 1A: 'we generate approximately 7% of our annual sales from China'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $24.96, but acceptable to hold if already in. Reason: Thin upside margin: 3.9%. Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $25.97 (+4.0%), stop $23.50 (−6.2%), A.R:R 0.4:1. Score 6.0/10, moderate confidence.
Take-profit target: $25.97 (+4.0% upside). Target $25.97 (+4.0%), stop $23.50 (−6.2%), A.R:R 0.4:1. Stop-loss: $23.50.
Thin upside margin: 3.9%.
Envista Holdings Corporation trades at a P/E of 57.2 (forward 14.9). TrendMatrix value score: 6.8/10. Verdict: Hold.
21 analysts cover NVST with a consensus score of 3.9/5. Average price target: $30.
What does Envista Holdings Corporation do?Envista Holdings is a global dental products company with $2.7B in 2025 sales through Specialty Products & Technologies...
Envista Holdings is a global dental products company with $2.7B in 2025 sales through Specialty Products & Technologies (Nobel Biocare implants, Ormco orthodontics; 64% of sales) and Equipment & Consumables (DEXIS imaging, Kerr materials; 36%). Revenue comes from dentists, DSOs, and dental labs in 130+ countries; 51% North America and 49% international.